CARM: Carisma Therapeutics, Inc. Stock

by  •  • Comments Off on CARM: Carisma Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.28
Enterprise Value ($M) -8.63
Book Value ($M) -27.91
Book Value / Share -0.67
Price / Book -0.33
NCAV ($M) -34.54
NCAV / Share -0.83
Price / NCAV -0.27

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.82
Return on Equity (ROE) -5.55

Liquidity (mrq)
Quick Ratio 1.48
Current Ratio 1.48

Balance Sheet (mrq) ($M)
Current Assets 23.82
Assets 30.46
Liabilities 58.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 19.63
Operating Income -62.18
Net Income -60.48
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -59.92
Cash from Investing -0.12
Cash from Financing 0.34

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-28 13D/A HealthCap VII, L.P. 8.20 0.00
2024-03-13 13G AbbVie Biotechnology Ltd 6.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 106,625 389,677 27.36
2025-04-02 267,254 613,645 43.55
2025-04-01 356,147 897,778 39.67
2025-03-31 29,510 117,219 25.18

(click for more detail)

Similar Companies
BHST – BioHarvest Sciences Inc. BTMD – biote Corp.
CADL – Candel Therapeutics, Inc. CHRS – Coherus BioSciences, Inc.
CLSD – Clearside Biomedical, Inc.


Financial data and stock pages provided by
Fintel.io